Revista de Oncología Integrativa

New Developments in Management of Meningioma

Abstract

George Fotakopoulos, Eleni Tsianaka, Vasilios Panagiotopoulos and Kostas Fountas

Introduction: The incidence of Meningiomas, indicating of the population-based studies, is approximately 13-26% of all primary intracranial tumors.
Methods: We searched PubMed for studies related to meningiomas published over the last 6 years (from May 2009) and retrieved 2104.
Results: Surgery remains the main choice of treatment at meningiomas and the combination with the endovascular treatment and/or Stereotactic radiosurgery provide a better and safer therapeutic strategy. In atypical and subtotal excised or recurrent meningiomas, conventional radiotherapy should be performed. Chemotherapeutic agents also, should be used in specific cases, because of questionable effectiveness and considerably side effects.
Conclusion: Even the recent technological developments, which give rise to better therapeutic options, the "gold standard" of meningiomas treatment, still remain challenging.